SG10201404755SA - Trihydrochloride Forms Of A Dihydropteridinone Derivative And Processes For Preparation - Google Patents
Trihydrochloride Forms Of A Dihydropteridinone Derivative And Processes For PreparationInfo
- Publication number
- SG10201404755SA SG10201404755SA SG10201404755SA SG10201404755SA SG10201404755SA SG 10201404755S A SG10201404755S A SG 10201404755SA SG 10201404755S A SG10201404755S A SG 10201404755SA SG 10201404755S A SG10201404755S A SG 10201404755SA SG 10201404755S A SG10201404755S A SG 10201404755SA
- Authority
- SG
- Singapore
- Prior art keywords
- processes
- preparation
- trihydrochloride
- forms
- dihydropteridinone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06101414 | 2006-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201404755SA true SG10201404755SA (en) | 2014-10-30 |
Family
ID=38008126
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201404755SA SG10201404755SA (en) | 2006-02-08 | 2007-02-07 | Trihydrochloride Forms Of A Dihydropteridinone Derivative And Processes For Preparation |
SG201100894-3A SG169397A1 (en) | 2006-02-08 | 2007-02-07 | Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201100894-3A SG169397A1 (en) | 2006-02-08 | 2007-02-07 | Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
Country Status (22)
Country | Link |
---|---|
US (3) | US7439358B2 (zh) |
EP (2) | EP1984367A1 (zh) |
JP (1) | JP5134552B2 (zh) |
KR (2) | KR101462879B1 (zh) |
CN (2) | CN101379064B (zh) |
AR (1) | AR059349A1 (zh) |
AU (1) | AU2007213752B2 (zh) |
BR (1) | BRPI0707604A8 (zh) |
CA (1) | CA2635834C (zh) |
EA (2) | EA015389B1 (zh) |
EC (1) | ECSP088589A (zh) |
HK (2) | HK1158628A1 (zh) |
IL (2) | IL193217A (zh) |
NO (1) | NO20082610L (zh) |
NZ (2) | NZ606264A (zh) |
PE (2) | PE20110100A1 (zh) |
SG (2) | SG10201404755SA (zh) |
TW (1) | TW200738716A (zh) |
UA (2) | UA101060C2 (zh) |
UY (1) | UY30136A1 (zh) |
WO (1) | WO2007090844A1 (zh) |
ZA (1) | ZA200804587B (zh) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
DE102004029784A1 (de) * | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel |
DE102004033670A1 (de) | 2004-07-09 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel |
US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
US20060035903A1 (en) * | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
US7728134B2 (en) | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
US20060074088A1 (en) * | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
US20060058311A1 (en) | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
EP1630163A1 (de) * | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
EP1632493A1 (de) * | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102004058337A1 (de) * | 2004-12-02 | 2006-06-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten |
US7439358B2 (en) * | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
TW200808325A (en) | 2006-07-06 | 2008-02-16 | Astrazeneca Ab | Novel compounds |
MX2009008084A (es) | 2007-02-01 | 2009-10-12 | Astrazeneca Ab | Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90. |
EP3098223A1 (en) * | 2007-08-03 | 2016-11-30 | Boehringer Ingelheim International GmbH | Crystalline form of a dihydropteridione derivative |
WO2009040556A1 (en) | 2007-09-28 | 2009-04-02 | Cyclacel Limited | Pyrimidine derivatives as protein kinase inhibitors |
JP5400791B2 (ja) | 2007-12-04 | 2014-01-29 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | 置換ジヒドロプテリジン−6−オン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用 |
EP2112152A1 (en) | 2008-04-22 | 2009-10-28 | GPC Biotech AG | Dihydropteridinones as Plk Inhibitors |
EP2325185A1 (en) | 2009-10-28 | 2011-05-25 | GPC Biotech AG | Plk inhibitor |
US8445503B2 (en) * | 2009-12-23 | 2013-05-21 | Elan Pharmaceuticals, Inc. | Inhibitors of polo-like kinase |
US8546566B2 (en) * | 2010-10-12 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
US9358233B2 (en) | 2010-11-29 | 2016-06-07 | Boehringer Ingelheim International Gmbh | Method for treating acute myeloid leukemia |
US20130131069A1 (en) | 2011-05-13 | 2013-05-23 | Boehringer Ingelheim International Gmbh | Method for treatment of solid malignancies including advanced or metastatic solid malignancies |
US9370535B2 (en) * | 2011-05-17 | 2016-06-21 | Boehringer Ingelheim International Gmbh | Method for treatment of advanced solid tumors |
US20140154304A1 (en) | 2012-11-30 | 2014-06-05 | Boehringer Ingelheim International Gmbh | Combination therapy with volasertib |
EA201600133A1 (ru) * | 2013-07-26 | 2016-07-29 | Бёрингер Ингельхайм Интернациональ Гмбх | Воласертиб в комбинации с децитабином для лечения острого миелоидного лейкоза и миелодиспластического синдрома |
JP2016525532A (ja) | 2013-07-26 | 2016-08-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 骨髄異形成症候群の処置 |
CN104003989B (zh) | 2014-05-26 | 2015-11-11 | 苏州明锐医药科技有限公司 | 伏拉塞替及其中间体的制备方法 |
US9867831B2 (en) | 2014-10-01 | 2018-01-16 | Boehringer Ingelheim International Gmbh | Combination treatment of acute myeloid leukemia and myelodysplastic syndrome |
CN105646398B (zh) * | 2014-12-05 | 2018-09-07 | 上海医药工业研究院 | N-((1r,4r)-4-(4-(环丙基甲基)哌嗪-1-基)环己基)乙酰胺的制备方法 |
WO2016206619A1 (zh) * | 2015-06-26 | 2016-12-29 | 苏州晶云药物科技有限公司 | Volasertib及其三盐酸盐的新晶型 |
US20210038602A1 (en) | 2018-01-25 | 2021-02-11 | Boehringer Ingelheim International Gmbh | Combination treatment of acute myeloid leukemia |
TW202404636A (zh) | 2022-04-08 | 2024-02-01 | 美商英伊布里克斯公司 | Dr5促效劑及plk1抑制劑或cdk抑制劑之組合療法 |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8303657A (nl) | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
JPH0276860A (ja) | 1987-10-05 | 1990-03-16 | Toyo Jozo Co Ltd | 6−置換アルコキシ−2−オキソ−1,2−ジヒドロキノキサリン誘導体 |
EP0347146B1 (en) | 1988-06-16 | 1993-09-01 | Smith Kline & French Laboratories Limited | Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
FR2645152B1 (fr) * | 1989-03-30 | 1991-05-31 | Lipha | 3h-pteridinones-4, procedes de preparation et medicaments les contenant |
US5043270A (en) * | 1989-03-31 | 1991-08-27 | The Board Of Trustees Of The Leland Stanford Junior University | Intronic overexpression vectors |
CA2029651C (en) | 1989-11-17 | 2000-06-06 | David D. Davey | Tricyclic pteridinones and a process for their preparation |
US5198547A (en) * | 1992-03-16 | 1993-03-30 | South Alabama Medical Science Foundation, Usa | Process for N5-formylating tetrahydropteridines |
TW274550B (zh) * | 1992-09-26 | 1996-04-21 | Hoechst Ag | |
EP1195372A1 (en) * | 1994-04-18 | 2002-04-10 | Mitsubishi Pharma Corporation | N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
GB9418499D0 (en) * | 1994-09-14 | 1994-11-02 | Ciba Geigy Ag | Process for producing n-methylated organic pigments |
CO4410191A1 (es) | 1994-09-19 | 1997-01-09 | Lilly Co Eli | SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS |
IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
WO1996036597A1 (en) * | 1995-05-19 | 1996-11-21 | Novartis Ag | Process for the catalytic hydrogenation of aromatic nitro compounds |
US5698556A (en) * | 1995-06-07 | 1997-12-16 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
JP3887836B2 (ja) * | 1995-12-21 | 2007-02-28 | 東ソー株式会社 | N−メチルイミダゾール類の製造法 |
RS49597B (sr) | 1996-09-23 | 2007-06-04 | Eli Lilly And Company, | Olanzapin dihidrat d |
IL140868A0 (en) * | 1998-08-11 | 2002-02-10 | Pfizer Prod Inc | Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
WO2001019825A1 (en) | 1999-09-15 | 2001-03-22 | Warner-Lambert Company | Pteridinones as kinase inhibitors |
GB2359551A (en) * | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
SK12472002A3 (sk) | 2000-03-06 | 2003-04-01 | Warner-Lambert Company | 5-Alkylpyrido[2,3-d]pyrimidínové inhibítory tyrosínových kináz |
DE10018783A1 (de) | 2000-04-15 | 2001-10-25 | Fresenius Kabi De Gmbh | Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt |
US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
DE10058119A1 (de) * | 2000-11-22 | 2002-05-23 | Bayer Ag | Pepinotan-Kit |
US6756374B2 (en) | 2001-01-22 | 2004-06-29 | Hoffmann-La Roche Inc. | Diaminothiazoles having antiproliferative activity |
US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
WO2002076985A1 (en) | 2001-03-23 | 2002-10-03 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
WO2002076954A1 (en) | 2001-03-23 | 2002-10-03 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
WO2003020722A1 (de) | 2001-09-04 | 2003-03-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel |
US6806272B2 (en) * | 2001-09-04 | 2004-10-19 | Boehringer Ingelheim Pharma Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
AU2002217111B2 (en) * | 2001-12-14 | 2007-05-31 | Merck Serono Sa | Methods of inducing ovulation using a non-polypeptide cAMP level modulator |
CN1649853A (zh) * | 2002-05-03 | 2005-08-03 | 舍林股份公司 | 噻唑烷酮类化合物、其制备方法以及作为药物的应用 |
FR2843114B1 (fr) | 2002-08-01 | 2004-09-10 | Poudres & Explosifs Ste Nale | Procede de monomethylation d'heterocycles azotes |
BR0313160A (pt) | 2002-08-08 | 2005-07-12 | Smithkline Beecham Corp | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto |
US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
GB2398565A (en) * | 2003-02-18 | 2004-08-25 | Cipla Ltd | Imatinib preparation and salts |
UA80743C2 (en) | 2003-02-26 | 2007-10-25 | Boehringer Ingelheim Pharma | Dihydropteridinones, method for the production and use thereof in the form of drugs |
US6861422B2 (en) * | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
EP1605971B1 (en) | 2003-03-26 | 2010-05-26 | Wyeth a Corporation of the State of Delaware | Immunogenic composition and methods |
WO2004093848A2 (en) | 2003-04-14 | 2004-11-04 | Vectura Ltd | Dry power inhaler devices and dry power formulations for enhancing dosing efficiency |
JP2007517828A (ja) * | 2004-01-17 | 2007-07-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 気道の疾患を治療するための置換プテリジンの使用 |
DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
DE102004029784A1 (de) * | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel |
DE102004033670A1 (de) | 2004-07-09 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel |
DE102004034623A1 (de) * | 2004-07-16 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US20060058311A1 (en) * | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
US20060074088A1 (en) * | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
US20060035903A1 (en) * | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
US7728134B2 (en) * | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
EP1632493A1 (de) * | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
EP1630163A1 (de) * | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
CA2575804A1 (en) * | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim International Gmbh | Pteridinones used as plk (polo like kinase) inhibitors |
EP1784406A1 (de) * | 2004-08-27 | 2007-05-16 | Boehringer Ingelheim International GmbH | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel |
DE102004058337A1 (de) * | 2004-12-02 | 2006-06-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten |
JP2009503014A (ja) * | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器系疾患の治療におけるジヒドロプテリジノン |
US20090306101A1 (en) | 2005-11-11 | 2009-12-10 | Flavio Solca | Combination treatment of cancer comprising egfr/her2 inhibitors |
US7439358B2 (en) | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
US20090023733A1 (en) * | 2006-03-07 | 2009-01-22 | Peter Cage | Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
AU2007247190A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
EP3098223A1 (en) | 2007-08-03 | 2016-11-30 | Boehringer Ingelheim International GmbH | Crystalline form of a dihydropteridione derivative |
JP4642085B2 (ja) | 2008-01-17 | 2011-03-02 | 日本下水道事業団 | 予測健全度を利用した施設管理および更新計画システム |
EP2100894A1 (en) | 2008-03-12 | 2009-09-16 | 4Sc Ag | Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors |
EP2509592A1 (en) | 2009-12-07 | 2012-10-17 | Boehringer Ingelheim International GmbH | Bibw 2992 for use in the treatment of triple negative breast cancer |
EP2536725B1 (en) | 2010-02-17 | 2015-10-28 | Boehringer Ingelheim International GmbH | Dihydropteridinones, method for production and use thereof |
US8546566B2 (en) | 2010-10-12 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
US9358233B2 (en) | 2010-11-29 | 2016-06-07 | Boehringer Ingelheim International Gmbh | Method for treating acute myeloid leukemia |
US20130131069A1 (en) | 2011-05-13 | 2013-05-23 | Boehringer Ingelheim International Gmbh | Method for treatment of solid malignancies including advanced or metastatic solid malignancies |
US9370535B2 (en) | 2011-05-17 | 2016-06-21 | Boehringer Ingelheim International Gmbh | Method for treatment of advanced solid tumors |
-
2007
- 2007-01-30 US US11/668,681 patent/US7439358B2/en active Active
- 2007-02-06 PE PE2010000509A patent/PE20110100A1/es not_active Application Discontinuation
- 2007-02-06 PE PE2007000127A patent/PE20071248A1/es not_active Application Discontinuation
- 2007-02-07 CN CN2007800050047A patent/CN101379064B/zh not_active Expired - Fee Related
- 2007-02-07 KR KR1020147013673A patent/KR101462879B1/ko not_active IP Right Cessation
- 2007-02-07 CA CA2635834A patent/CA2635834C/en not_active Expired - Fee Related
- 2007-02-07 EA EA200801769A patent/EA015389B1/ru not_active IP Right Cessation
- 2007-02-07 TW TW096104368A patent/TW200738716A/zh unknown
- 2007-02-07 CN CN201010580571.9A patent/CN102093360B/zh not_active Expired - Fee Related
- 2007-02-07 EP EP07704397A patent/EP1984367A1/en not_active Ceased
- 2007-02-07 AR ARP070100503A patent/AR059349A1/es active Pending
- 2007-02-07 SG SG10201404755SA patent/SG10201404755SA/en unknown
- 2007-02-07 UA UAA201104532A patent/UA101060C2/ru unknown
- 2007-02-07 SG SG201100894-3A patent/SG169397A1/en unknown
- 2007-02-07 AU AU2007213752A patent/AU2007213752B2/en not_active Ceased
- 2007-02-07 NZ NZ606264A patent/NZ606264A/en not_active IP Right Cessation
- 2007-02-07 BR BRPI0707604A patent/BRPI0707604A8/pt not_active IP Right Cessation
- 2007-02-07 WO PCT/EP2007/051139 patent/WO2007090844A1/en active Application Filing
- 2007-02-07 NZ NZ570987A patent/NZ570987A/en not_active IP Right Cessation
- 2007-02-07 EP EP12180787.9A patent/EP2543669A3/en not_active Ceased
- 2007-02-07 KR KR1020087021673A patent/KR101445114B1/ko not_active IP Right Cessation
- 2007-02-07 JP JP2008553753A patent/JP5134552B2/ja active Active
- 2007-02-07 EA EA201100638A patent/EA018663B1/ru not_active IP Right Cessation
- 2007-02-08 UY UY30136A patent/UY30136A1/es not_active Application Discontinuation
- 2007-07-02 UA UAA200810889A patent/UA95625C2/ru unknown
-
2008
- 2008-05-27 ZA ZA200804587A patent/ZA200804587B/xx unknown
- 2008-06-04 NO NO20082610A patent/NO20082610L/no not_active Application Discontinuation
- 2008-06-27 EC EC2008008589A patent/ECSP088589A/es unknown
- 2008-08-04 IL IL193217A patent/IL193217A/en not_active IP Right Cessation
- 2008-09-17 US US12/212,188 patent/US8188086B2/en active Active
-
2009
- 2009-07-28 HK HK11112923.4A patent/HK1158628A1/zh not_active IP Right Cessation
- 2009-07-28 HK HK09106923.0A patent/HK1127772A1/xx not_active IP Right Cessation
-
2012
- 2012-04-27 US US13/457,991 patent/US8664222B2/en active Active
-
2015
- 2015-01-15 IL IL236736A patent/IL236736A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL236736A0 (en) | Trihydrochloride forms of dihydropyridine derivatives and processes for their preparation | |
IL194522A0 (en) | Process for the preparation of prasugrel | |
HK1126760A1 (en) | Novel pyrone-indole derivatives and process for their preparation | |
IL198117A0 (en) | Process for preparing indol-5-oxy-quinazoline derivatives and intermediates | |
IL196228A0 (en) | 4-hydroxythiobenzamide derivatives of drugs | |
GB0624963D0 (en) | Derivatives of 188-Glycyrrhetinic Acid | |
HK1139986A1 (en) | Pharmaceutical manufacturing methods | |
PL2146944T3 (pl) | Sposób otrzymywania folianów znakowanych fluorem-18 | |
EP2069329A4 (en) | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS | |
ZA200807614B (en) | Buprenorphine derivatives and uses thereof | |
IL237789A0 (en) | Methods for using thiazole history | |
ZA200900230B (en) | 4-hydroxythiobenzamide derivatives of drugs | |
EP1974725A4 (en) | PREPARATION WITH DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF | |
EP2121729A4 (en) | PHARMACEUTICAL, SUBSTANTIVE SALTS OF THYMODEPRESSINE AND METHOD FOR THE PRODUCTION THEREOF | |
ZA200809112B (en) | N-oxides of pyridylmethylpiperazine and -piperidine derivatives | |
HK1129687A1 (en) | A process for the preparation of poly-alfa-glutamic acid and derivatives thereof | |
GB2437920B (en) | Sleeping aid | |
GB0903324D0 (en) | A Method of brewing ethanol | |
IL194737A0 (en) | 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof | |
IL196031A0 (en) | Polymorph of esomeprazole and process for its preparation | |
EP1934388A4 (en) | METHOD FOR THE DEVELOPMENT OF MEDICAMENTS | |
GB2469959B (en) | Dioctatin derivatives and production process thereof | |
EG26107A (en) | Way to prepare medicine Alandral | |
IL198836A0 (en) | Processes for preparation of 9-haloacetamidomidominocyclines | |
GB0617524D0 (en) | Method of providing a fitting |